UM is the coordinator of the Young Universities for the Future of Europe (YUFE) alliance, a major strategic partnership between ten young, research-intensive universities from as many European countries. The YUFE alliance, together with its four non-governmental and private sector partners, aims at...
It is with great sadness that we learned of the passing of Geert Hofstede, professor emeritus of Organizational Anthropology and International Management. Geert reached the blessed age of 91. This world-renowned cultural scholar is survived by his wife Maaike, his four children, ten grandchildren...
During the Dies, the winners of the thesis prizes were announced. The thesis prizes are awarded to master’s students who have written an outstanding master’s thesis. Alumnus Matthijs Korrevaar was among the winners. He investigated how rents in several European cities have developed over the last...
Mike Gerards is currently working at The Maastricht Centre for Systems Biology (MaCSBio). His project focuses on the identification and functional characterization of novel genes involved in mitochondria (more specifically in mtDNA replication) and screening these genes for mutations in patients.
Interdisciplinary research contributing scientific knowledge and expertise on sustainability science for policymaking and innovation. MSI pursues sustainable development at the local and regional levels, essential components of global sustainability.
Content creators, exercising their freedom of expression, may use trade marks in their content in a way that might damage the interests of trade mark proprietors (e.g. use of Nike shoes in a porn movie). How does EU trade mark law address these different interests?
Should this symbolic change of French law be applauded?
The ongoing COVID-19 pandemic is arguably one of the biggest crises of modern times. The conflict between the search for a vaccine, and the artificial scarcity created by patent law, has created a catch-22 situation. How will patent law apply to a vaccine under these circumstances?
The advancement of big data may lead to a revolution in the health sector by enabling the personalization of medicine. However, there are still uncertainties regarding the ownership of the data available, and also whether users should be entitled to compensation for the utilisation of their data.
